The Top Stock to Watch as the Future Turns Green
California is the biggest market in the world for MJ and one company is about to open one of the largest facilities in the state. This could be the hottest MJ ground-floor play around!
Continue Reading

ORGO Insider Trading (Organogenesis)

Insider Ownership Percentage: 57.20%
Insider Buying (Last 12 Months): $3,999,094.76
Insider Selling (Last 12 Months): $3,281,101.41

Organogenesis Insider Trading History Chart

Organogenesis Share Price & Price History

▲ +1.2 (7.89%)
As of 03/1/2021 01:00 AM ET
Days: 30 | 90 | 365
World's 2nd Richest Man Is About To Shock The World
Elon Musk changed online payment processing with Paypal. He's changing space exploration with SpaceX and the auto industry...
See what Elon is up to now.

Organogenesis Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/18/2021Gary S GillheeneyCEOSell16,663$12.85$214,119.55245,845  
2/16/2021Gary S GillheeneyCEOSell111,406$13.12$1,461,646.72416,954  
2/11/2021Gary S GillheeneyCEOSell69,127$13.82$955,335.14416,954  
2/11/2021Glenn H NussdorfDirectorSell200,000$3.25$650,000.0068,594,976  
12/2/2020Wayne D MackieDirectorBuy38,710$5.26$203,614.60200,000  
11/24/2020Avista Capital Managing MemberDirectorBuy100$5.00$500.00  
11/19/2020Avista Capital Managing MemberDirectorBuy36,127$4.97$179,551.19  
11/17/2020Michael W KatzMajor ShareholderBuy20,829$3.25$67,694.2534,432  
11/17/2020Wayne D MackieDirectorBuy42,726$3.25$138,859.50161,290  
3/16/2020Avista Capital Managing MemberDirectorBuy542,349$3.92$2,126,008.08  
3/12/2020Avista Capital Managing MemberDirectorBuy332,349$3.86$1,282,867.14  
11/26/2019Avista Capital Managing MemberDirectorBuy6,000,000$5.00$30,000,000.00  
9/13/2019Michael W KatzMajor ShareholderBuy3,603$6.00$21,618.00
9/12/2019Avista Capital Managing MemberDirectorBuy860,900$5.99$5,156,791.00
9/10/2019Avista Capital Managing MemberDirectorBuy537,000$5.18$2,781,660.00
9/5/2019Alan A AdesDirectorBuy105,100$4.50$472,950.0067,896,723  
9/4/2019Michael W KatzMajor ShareholderBuy10,000$4.50$45,000.0010,000  
9/3/2019Arthur S LeibowitzDirectorBuy5,000$4.20$21,000.005,000  
See Full Table

SEC Filings (Institutional Ownership Changes) for Organogenesis (NASDAQ:ORGO)

4.62% of Organogenesis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Organogenesis Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/19/2021JPMorgan Chase & Co.62,726$0.47M0.0%+317.5%0.058%
2/17/2021Wealth Dimensions Group Ltd.60,900$0.46M0.4%N/A0.057%
2/16/2021Walleye Trading LLC50,098$0.38M0.0%N/A0.046%
2/16/2021Walleye Capital LLC108,834$0.82M0.1%N/A0.101%
2/16/2021Zacks Investment Management83,705$0.63M0.0%N/A0.078%
2/16/2021Pura Vida Investments LLC1,807,554$13.61M0.5%N/A1.677%
2/16/2021Nuveen Asset Management LLC81,957$0.62M0.0%+76.3%0.076%
2/16/2021New York Life Investments Alternatives124,263$0.94M0.6%N/A0.115%
2/16/2021Avidity Partners Management LP5,521,500$41.58M1.3%N/A5.123%
2/16/2021Gyon Technologies Capital Management LP35,453$0.27M0.1%N/A0.033%
2/16/2021Charles Schwab Investment Management Inc.359,626$2.71M0.0%+117.1%0.334%
2/13/2021American International Group Inc.13,955$0.11M0.0%+15.3%0.013%
2/12/2021Laurion Capital Management LP562,980$4.24M0.0%N/A0.522%
2/12/2021Federated Hermes Inc.10,406$78K0.0%+80.7%0.010%
2/11/2021Lazard Asset Management LLC9,840$74K0.0%+754.2%0.009%
2/11/2021Northern Trust Corp332,596$2.50M0.0%+23.5%0.309%
2/11/2021Barclays PLC13,142$99K0.0%-10.0%0.012%
2/11/2021Citigroup Inc.4,176$31K0.0%+329.6%0.004%
2/10/2021Rhumbline Advisers14,088$0.11M0.0%+14.3%0.013%
2/10/2021Renaissance Technologies LLC646,300$4.87M0.0%+237.0%0.600%
2/9/2021Wells Fargo & Company MN63,200$0.48M0.0%+110.9%0.059%
2/9/2021Bank of New York Mellon Corp97,030$0.73M0.0%+73.6%0.090%
2/8/2021Alliancebernstein L.P.35,500$0.27M0.0%+17.2%0.033%
2/5/2021BlackRock Inc.1,264,397$9.52M0.0%+19.5%1.173%
2/4/2021State of Wisconsin Investment Board15,000$0.11M0.0%-11.2%0.014%
1/29/2021Emerald Mutual Fund Advisers Trust1,846,153$13.90M0.5%N/A1.713%
1/29/2021Emerald Advisers LLC3,500$26K0.0%N/A0.003%
1/27/2021CWM LLC4,000$30K0.0%+66.8%0.004%
11/16/2020Squarepoint Ops LLC67,502$0.26M0.0%+227.4%0.063%
11/16/2020ArrowMark Colorado Holdings LLC11,832$45K0.0%-57.5%0.011%
11/13/2020Morgan Stanley13,600$52K0.0%-32.0%0.013%
11/13/2020Charles Schwab Investment Management Inc.165,676$0.64M0.0%+10.8%0.154%
11/12/2020JPMorgan Chase & Co.15,024$58K0.0%-17.9%0.014%
11/10/2020State Street Corp259,014$1M0.0%+33.2%0.246%
11/6/2020BlackRock Inc.1,057,985$4.06M0.0%-0.4%1.004%
11/6/2020GSA Capital Partners LLP16,953$65K0.0%N/A0.016%
11/2/2020Hussman Strategic Advisors Inc.100,000$0.38M0.1%-50.0%0.095%
9/15/2020Two Sigma Advisers LP52,900$0.20M0.0%-6.2%0.050%
8/25/2020Nuveen Asset Management LLC46,000$0.18M0.0%+75.2%0.044%
8/20/2020Charles Schwab Investment Management Inc.149,480$0.58M0.0%+21.4%0.142%
8/17/2020Jane Street Group LLC14,874$57K0.0%N/A0.014%
8/14/2020Prosight Management LP535,616$2.06M0.9%-20.3%0.508%
8/12/2020Bank of Montreal Can130,974$0.44M0.0%+5.5%0.123%
8/12/2020American International Group Inc.12,379$48K0.0%+74.7%0.012%
8/12/2020Goldman Sachs Group Inc.54,576$0.21M0.0%+202.3%0.051%
8/12/2020Bank of New York Mellon Corp55,338$0.21M0.0%+95.0%0.052%
6/19/2020State Street Corp171,788$0.56M0.0%+4.3%0.162%
5/15/2020Squarepoint Ops LLC80,706$0.26M0.0%+31.1%0.076%
5/15/2020Morgan Stanley18,461$60K0.0%+23.2%0.017%
5/15/2020Two Sigma Investments LP46,761$0.15M0.0%-45.1%0.044%
5/15/2020Two Sigma Advisers LP56,400$0.18M0.0%+71.4%0.053%
5/15/2020Prosight Management LP672,275$2.17M1.0%+8.8%0.634%
5/14/2020Wells Fargo & Company MN10,368$33K0.0%-41.4%0.010%
5/14/2020Geode Capital Management LLC242,105$0.78M0.0%+21.9%0.230%
5/14/2020Alliancebernstein L.P.16,000$52K0.0%N/A0.015%
5/12/2020Granahan Investment Management Inc. MA285,990$0.92M0.0%+14.4%0.271%
5/12/2020JPMorgan Chase & Co.20,028$65K0.0%+41.3%0.019%
5/11/2020State Street Corp171,788$0.56M0.0%+4.3%0.163%
5/11/2020Private Advisors LLC45,013$0.15M0.1%+17.8%0.043%
5/1/2020BlackRock Inc.651,085$2.10M0.0%+3.7%0.618%
2/20/2020Geode Capital Management LLC198,579$0.96M0.0%+12.7%0.210%
2/14/2020Marshall Wace LLP37,418$0.18M0.0%N/A0.039%
2/14/2020Goldman Sachs Group Inc.19,131$92K0.0%N/A0.020%
2/14/2020UBS Group AG13,560$65K0.0%+30.2%0.014%
2/13/2020Laurion Capital Management LP25,000$0.12M0.0%N/A0.026%
2/13/2020K2 Principal Fund L.P.89,191$0.43M0.0%N/A0.094%
2/13/2020Renaissance Technologies LLC35,300$0.17M0.0%N/A0.037%
2/12/2020Monashee Investment Management LLC115,818$0.56M0.5%+577.2%0.122%
2/10/2020Barclays PLC16,324$79K0.0%+214.3%0.017%
2/10/2020Bank of Montreal Can117,068$0.56M0.0%+12,569.7%0.124%
2/7/2020Tower Research Capital LLC TRC12,034$58K0.0%N/A0.013%
2/7/2020Charles Schwab Investment Management Inc.116,488$0.56M0.0%+97.7%0.123%
2/6/2020Guild Investment Management Inc.42,845$0.21M0.3%N/A0.045%
2/6/2020State Street Corp164,760$0.79M0.0%+30.9%0.174%
2/5/2020New York State Common Retirement Fund5,400$26K0.0%-60.0%0.006%
2/3/2020Private Advisors LLC38,203$0.18M0.2%N/A0.040%
1/31/2020Hussman Strategic Advisors Inc.200,000$0.96M0.3%N/A0.211%
11/27/2019State Street Corp125,843$0.83M0.0%+2.3%0.133%
8/14/2019Citadel Advisors LLC26,312$0.20M0.0%N/A0.029%
8/14/2019Vanguard Group Inc.323,292$2.46M0.0%+33.3%0.354%
8/13/2019BlackRock Inc.554,838$4.22M0.0%+716.3%0.607%
8/13/2019Northern Trust Corp41,066$0.31M0.0%+134.3%0.045%
8/12/2019Bank of New York Mellon Corp27,545$0.21M0.0%N/A0.030%
8/10/2019Charles Schwab Investment Management Inc.86,495$0.66M0.0%+36.6%0.095%
6/30/2019Moors & Cabot Inc.91,350$0.69M0.1%N/A0.100%
Data available starting January 2016

See Full Table
Organogenesis logo
Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.
Read More

Today's Range

Now: $16.41

50 Day Range

MA: $11.72

52 Week Range

Now: $16.41


1,155,253 shs

Average Volume

924,484 shs

Market Capitalization

$1.77 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Organogenesis?

Organogenesis' top insider shareholders include:
  1. Glenn H Nussdorf (Director)
  2. Alan A Ades (Director)
  3. Gary S Gillheeney (CEO)
  4. Wayne D Mackie (Director)
  5. Michael W Katz (Major Shareholder)
  6. Arthur S Leibowitz (Director)
  7. Avista Capital Managing Member (Director)

Who are the major institutional investors of Organogenesis?

Organogenesis' top institutional investors include:
  1. Avidity Partners Management LP — 5.12%
  2. Emerald Mutual Fund Advisers Trust — 1.71%
  3. Pura Vida Investments LLC — 1.68%
  4. BlackRock Inc. — 1.17%
  5. Renaissance Technologies LLC — 0.60%
  6. Laurion Capital Management LP — 0.52%

Which institutional investors are selling Organogenesis stock?

During the previous quarter, ORGO stock was sold by these institutional investors:
  1. State of Wisconsin Investment Board
  2. Barclays PLC
In the previous year, company insiders that have sold Organogenesis company stock include:
  1. Glenn H Nussdorf (Director)
  2. Alan A Ades (Director)

Which institutional investors are buying Organogenesis stock?

During the last quarter, ORGO stock was acquired by institutional investors including:
  1. Avidity Partners Management LP
  2. Emerald Mutual Fund Advisers Trust
  3. Pura Vida Investments LLC
  4. Laurion Capital Management LP
  5. Renaissance Technologies LLC
  6. BlackRock Inc.
  7. Charles Schwab Investment Management Inc.
  8. New York Life Investments Alternatives
In the previous year, these company insiders have bought Organogenesis stock:
  1. Glenn H Nussdorf (Director)
  2. Alan A Ades (Director)
  3. Gary S Gillheeney (CEO)
  4. Wayne D Mackie (Director)
  5. Michael W Katz (Major Shareholder)
The Top Stock to Watch as the Future Turns Green
California is the biggest market in the world for MJ and one company is about to open one of the largest facilities in the state. This could be the hottest MJ ground-floor play around!
Continue Reading